APA aipamena

Bloudek, L. M., Makenbaeva, D., & Eaddy, M. (2015). Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors. Am Health Drug Benefits.

Chicago Style aipamena

Bloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.

MLA aipamena

Bloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.